Access is also planning to grant the agents a 30-day option to purchase up to an additional units to cover over-allotments, if any.
Deal Value (US$ Million) 25 Deal Type IPO Sub-Category Secondary Offering Deal Status Announced: 2009-10-27
Deal Participants
Target (Company) Access Pharmaceuticals, Inc.
Deal Rationale
Access Pharmaceuticals intends to use the proceeds from the offering to further develop its products and product candidates and for general working capital purposes.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index